Summary

Eligibility
for people ages 8 years and up (full criteria)
Location
at UCLA UCSF
Dates
study started
completion around
Principal Investigator
by Jeremy Keenan, MD, MPH (ucsf)
Headshot of Jeremy Keenan
Jeremy Keenan

Description

Summary

The Parasitic Ulcer Treatment Trial (PUTT) is a multi-center, parallel-group, randomized clinical trial. The purpose of this study is to determine whether including topical corticosteroids in a regimen for acanthamoeba keratitis (AK) will improve vision. Patients presenting to all enrollment centers with evidence of acanthamoeba keratitis will be eligible for the trial if there is evidence of ocular inflammation after 4 weeks of anti-amoebic therapy. Those who agree to participate will be randomized to one of two treatment groups:

  • Group 1: Topical corticosteroid
  • Group 2: Topical placebo

Keywords

Acanthamoeba Keratitis, corneal ulcer, steroids, Keratitis, Biguanides, Polihexanide, Polyhexamethylene biguanide (PHMB), Topical corticosteroid, Topical steroids

Eligibility

Locations

  • University of California, Los Angeles not yet accepting patients
    Los Angeles California 90095 United States
  • University of California, San Francisco accepting new patients
    San Francisco California 94158 United States
  • Oregon Health and Science University accepting new patients
    Portland Oregon 97239 United States

Lead Scientist at University of California Health

  • Jeremy Keenan, MD, MPH (ucsf)
    Professor, Proctor Foundation, Chancellor/EVC/FAS. Authored (or co-authored) 336 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Jeremy Keenan, MD, MPH
ID
NCT06213649
Phase
Phase 3 Acanthamoeba Keratitis Research Study
Study Type
Interventional
Participants
Expecting 232 study participants
Last Updated